Claris Lifesciences Limited - Company Profile

It is a healthcare public limited company based in Ahmedabad, Gujarat, India, established in 1994.
1994 Ahmedabad, Gujarat, India Amalgamated
Last Updated:
About Claris Lifesciences Limited

Claris Lifesciences Limited, a amalgamated public limited company, was established on 19 July 1994 in Ahmedabad, Gujarat, India. Engaging in medical consumables & supplies within the trade sector, it holds CIN: U85110GJ1994PLC022543. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹120.51 Cr and a paid-up capital of ₹54.57 Cr.

Formerly known as Oragle Laboratories Limited, Core Laboratories Limited. It upholds a compliant status. Employing 162 professional, Its leadership includes Chandrasingh Shivrambhai Purohit (Cfo), Arjun Sushilkumar Handa (Managing Director), Aditya Sushilkumar Handa (Director). Past directors included Hirenkumar Mahendrabhai Patel, Chandrasingh Shivrambhai Purohit, Arjun Sushilkumar Handa. It holds no open charges and ₹3,276.28 Cr settled loans. Its latest AGM occurred on 28 September 2021, with the balance sheet filed on 31 March 2021. It is based at Claris Corporate Headquarters, Nr. Parimal Crossing, Ellisbridge,, Ahmedabad, Gujarat, 380006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110GJ1994PLC022543

  • Registration Number

    022543

  • Incorporation Date

    19 July 1994

  • Authorized Capital

    ₹120.51 Cr

  • Paid-Up Capital

    ₹54.57 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 120.51 Cr
  • Paid Up Capital ₹ 54.57 Cr
  • Company Age 31 Year, 7 Months
  • Last Filing with ROC 31 Mar 2021
  • Satisfied Charges ₹ 3,276.28 Cr
  • Revenue Growth **** -91.01%
  • Profit Growth **** 94.55%
  • Ebitda **** 78.42%
  • Net Worth -2.40%
  • Total Assets -1.99%
Company report

Claris Lifesciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Claris Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Claris Lifesciences Limited?
Current Directors
Name Designation Appointment Date Status
Chandrasingh Shivrambhai Purohit Cfo 09 May 2014 Current
Arjun Sushilkumar Handa Managing Director 26 Sep 2014 Current
Aditya Sushilkumar Handa Director 13 Jun 2006 Current
Anup Pravin Shah Director 23 Feb 2013 Current
Surrinder Lal Kapur Director 26 Sep 2008 Current
Kiritkumar Himatlal Kanjaria Company Secretary 13 Apr 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 27 Jan 2009 Past
Pramod Abcsdd Additional Director 30 Sep 2009 Past
Pramod Abcsdd Director 01 Jan 2008 Past
Pramod Abcsdd Alternate Director 28 Jan 2008 Past
Pramod Abcsdd Company Secretary 13 Apr 2013 Past
Pramod Abcsdd Director 14 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Claris Lifesciences.

Claris Lifesciences Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 91.01% decrease. The company also saw a substantial improvement in profitability, with a 94.55% increase in profit. The company's net worth dipped by a decrease of 2.4%.

Claris Lifesciences revenue growth over time
Claris Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-91.01%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-1.99%
*******
*******
*******
*******
Profit or Loss
*******
94.55%
*******
*******
*******
*******
Net Worth
*******
-2.40%
*******
*******
*******
*******
EBITDA
*******
78.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Claris Lifesciences?

In 2021, Claris Lifesciences had a promoter holding of 99.29% and a public holding of 0.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹32,762,757,072.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 1373.81 Cr
  • Credit Suisse Ag : 780.00 Cr
  • Centurion Bank Of Punjab Ltd. : 168.50 Cr
  • Indian Overseas Bank : 150.64 Cr
  • The Hongkong & Shanghai Banking Corporation Limited : 112.59 Cr
  • Others : 690.73 Cr
Latest Charge Details
Date Lender Amount Status
20 Dec 2017 Credit Suisse Ag ₹390.00 Cr Satisfied
20 Dec 2017 Credit Suisse Ag ₹390.00 Cr Satisfied
30 Sep 2016 Punjab National Bank ₹20.00 Cr Satisfied
12 Aug 2016 Icici Bank Limited ₹2.30 M Satisfied
24 May 2016 Icici Bank Limited ₹3.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Claris Lifesciences?

Claris Lifesciences has a workforce of 162 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Claris Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claris Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Claris Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    Claris Lifesciences Limited last Annual general meeting of members was held on 28 Sep 2021 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Claris Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad. was completed.

  • Charges

    The activity A charge registered on 12 Aug 2016 via Charge ID 100046036 with Icici Bank Limited was fully satisfied on 14 Aug 2019. was completed.

  • Charges

    A charge registered on 24 May 2016 via Charge ID 100032154 with Icici Bank Limited was fully satisfied on 24 May 2019. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 24 May 2016 via Charge ID 100032156 with Icici Bank Limited was fully satisfied on 24 May 2019. was documented.

  • Charges

    A charge registered on 24 May 2016 via Charge ID 100032158 with Icici Bank Limited was fully satisfied on 24 May 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Claris Lifesciences Limited?

The CIN of Claris Lifesciences Limited is U85110GJ1994PLC022543.

Where is Claris Lifesciences Limited headquartered?

Claris Lifesciences Limited is headquartered at Claris Corporate Headquarters, Nr. Parimal Crossing, Ellisbridge,, Ahmedabad, Gujarat, 380006.

When was Claris Lifesciences Limited incorporated?

Claris Lifesciences Limited was incorporated on 19 July 1994.

Who are the current directors of Claris Lifesciences Limited?

The current directors of Claris Lifesciences Limited are

What is the primary industry of Claris Lifesciences Limited?

The primary industry of Claris Lifesciences Limited is Trade.

Is Claris Lifesciences Limited a listed company?

Claris Lifesciences Limited is unlisted.

What is the capital structure of Claris Lifesciences Limited?

The authorized capital of Claris Lifesciences Limited is ₹120.51 Cr, and the paid-up capital is ₹54.57 Cr.

What is the compliance status of Claris Lifesciences Limited?

The compliance status of Claris Lifesciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available